Carolinas Wealth Consulting LLC Charles River Laboratories International, Inc. Transaction History

Carolinas Wealth Consulting LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$206.39 - $268.73 $206 - $268	1 New	1 $0
Q1 2023 May 15, 2023	SELL	$191.89 - $259.92 $1,918 - $2,599	-10 Reduced 21.74%	36 $7,000
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $8,392 - $11,524	46 New	46 $9,000
Q2 2022 Aug 16, 2022	SELL	$204.13 - $302.4 $6,532 - $9,676	-32 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$255.51 - $362.11 $2,044 - $2,896	8 Added 33.33%	32 $9,000
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $8,433 - $10,768	24 New	24 $9,000

695

52.2M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.45B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Carolinas Wealth Consulting LLC, based on Form 13F filings with the SEC.

Stay updated on Carolinas Wealth Consulting LLC with notifications on news.